HYUNDAI BIOLAND Co.Ltd - Asset Resilience Ratio
HYUNDAI BIOLAND Co.Ltd (052260) has an Asset Resilience Ratio of 0.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 052260 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how HYUNDAI BIOLAND Co.Ltd's Asset Resilience Ratio has changed over time. See HYUNDAI BIOLAND Co.Ltd book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down HYUNDAI BIOLAND Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see HYUNDAI BIOLAND Co.Ltd (052260) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩500.00 Million | 0.3% |
| Total Liquid Assets | ₩500.00 Million | 0.30% |
Asset Resilience Insights
- Limited Liquidity: HYUNDAI BIOLAND Co.Ltd maintains only 0.30% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
HYUNDAI BIOLAND Co.Ltd Industry Peers by Asset Resilience Ratio
Compare HYUNDAI BIOLAND Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
NeoPharm CO. LTD
KQ:092730 |
Personal & Household Products & Services | 53.07% |
|
Globon Co. Ltd
KQ:019660 |
Personal & Household Products & Services | 19.06% |
|
Gentrogroup Co. Ltd.
KQ:083660 |
Personal & Household Products & Services | 19.19% |
Annual Asset Resilience Ratio for HYUNDAI BIOLAND Co.Ltd (2011–2024)
The table below shows the annual Asset Resilience Ratio data for HYUNDAI BIOLAND Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 13.61% | ₩26.50 Billion ≈ $17.96 Million |
₩194.73 Billion ≈ $131.96 Million |
+1.08pp |
| 2023-12-31 | 12.53% | ₩23.06 Billion ≈ $15.63 Million |
₩184.07 Billion ≈ $124.74 Million |
+3.77pp |
| 2022-12-31 | 8.76% | ₩15.43 Billion ≈ $10.45 Million |
₩176.10 Billion ≈ $119.34 Million |
+0.23pp |
| 2021-12-31 | 8.53% | ₩14.74 Billion ≈ $9.99 Million |
₩172.74 Billion ≈ $117.07 Million |
+8.53pp |
| 2020-12-31 | 0.00% | ₩110.00 ≈ $0.07 |
₩187.66 Billion ≈ $127.17 Million |
+0.00pp |
| 2019-12-31 | 0.00% | ₩-3.32 Million ≈ $-2.25K |
₩209.05 Billion ≈ $141.67 Million |
-4.14pp |
| 2018-12-31 | 4.14% | ₩7.99 Billion ≈ $5.41 Million |
₩193.16 Billion ≈ $130.90 Million |
+4.27pp |
| 2017-12-31 | -0.14% | ₩-242.88 Million ≈ $-164.60K |
₩176.37 Billion ≈ $119.52 Million |
-6.09pp |
| 2016-12-31 | 5.95% | ₩9.98 Billion ≈ $6.77 Million |
₩167.67 Billion ≈ $113.63 Million |
-2.65pp |
| 2015-12-31 | 8.61% | ₩13.20 Billion ≈ $8.95 Million |
₩153.36 Billion ≈ $103.93 Million |
+8.60pp |
| 2014-12-31 | 0.01% | ₩7.36 Million ≈ $4.99K |
₩143.16 Billion ≈ $97.02 Million |
-5.69pp |
| 2013-12-31 | 5.69% | ₩8.11 Billion ≈ $5.50 Million |
₩142.53 Billion ≈ $96.59 Million |
+0.25pp |
| 2012-12-31 | 5.44% | ₩8.00 Billion ≈ $5.42 Million |
₩147.06 Billion ≈ $99.66 Million |
+5.42pp |
| 2011-12-31 | 0.01% | ₩19.10 Million ≈ $12.94K |
₩128.86 Billion ≈ $87.32 Million |
-- |
About HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more